With products now launched and a growing portfolio of products in development, Hibergene is seeking distributors globally. Distributors of Hibergene’s products can benefit from an expanding range of tests for human infectious diseases, all of which meet a significant unmet clinical need. These tests currently include Meningococcus, Group B Streptococcus, and C. difficile with tests for Mycoplasma Pneumoniae and Flu A/B in development.
Hibergene’s products have a strong reputation in the market, through their ease of use and their ability to provide accurate results rapidly. In addition, the tests can be deployed in a near patient setting ensuring patients can be quickly and accurately diagnosed.
Hibergene’s products are developed in conjunction with clinicians, ensuring that they can be used in a range of settings to provide improved patient diagnosis, and the company continues to work with clinicians in identifying new tests.
Contact us to join our growing network of distributors.